Ocimum Biosolutions CEO Wins Astia and Biospectrum Awards

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) December 17, 2008 -- Hyderabad, Andhra Pradesh, India | Gaithersburg, Maryland, USA. December 16, 2008

Ocimum Biosolutions, a leading integrated genomics company, today announced that Anuradha Acharya, CEO, has been awarded the Astia Life Science Innovators Award and the Biospectrum Entrepreneur of the Year award.
 
In its 4th year, the Astia Awards honor exceptional women innovators and recognize the investors and mentors who championed their success. Seven awards are presented each year within the three areas of innovators, investors and mentors.
 

The annual BioSpectrum Awards, which were started in 2003, recognize the exceptional contributions of the industry to the development of biotech sector in the country. The jury for the awards was headed by Varaprasad Reddy, Chairman, Shantha Biotech and comprised Prof. Vijay Chandru, Chairman, Strand Life Sciences; Dr Shrikumar Suryanarayan, Director General, Association of Biotechnology-Led Enterprises (ABLE), Bangalore; Tapan Ray, Director General, Organization of Pharmaceutical Producers of India (OPPI), Mumbai; A Ramesh, General Partner, APIDC-Venture East, Hyderabad; Narayanan Suresh, Group Editor, BioSpectrum; and Abraham Mathew, Chief Editor, BioSpectrum.
 
Anu Acharya said "It is an honor to receive these recognitions from Astia and Biospectrum. I would like to thank our global customers, partners, employees, investors and well wishers who made this happen. We will continue to hone our capabilities to provide integrated range of quality genomic solutions to our global clientele."

About Ocimum Biosolutions

Ocimum Biosolutions is a leading integrated genomics company providing comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.

For more information, please visit www.ocimumbio.com | www.genelogic.com.

awards     Biotechnology     investors     women CEO